BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7097268)

  • 21. [The concept of supersensitivity psychosis. The particular case of clozapine].
    Llorca PM; Penault F; Lançon C; Dufumier E; Vaiva G
    Encephale; 1999; 25(6):638-44. PubMed ID: 10668609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mania after withdrawal of isocarboxazid.
    Rothschild AJ
    J Clin Psychopharmacol; 1985 Dec; 5(6):340-2. PubMed ID: 4067000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder.
    Berk M; Dodd S; Kauer-Sant'anna M; Malhi GS; Bourin M; Kapczinski F; Norman T
    Acta Psychiatr Scand Suppl; 2007; (434):41-9. PubMed ID: 17688462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychotic phenomena in 257 young children and adolescents with bipolar I disorder: delusions and hallucinations (benign and pathological).
    Tillman R; Geller B; Klages T; Corrigan M; Bolhofner K; Zimerman B
    Bipolar Disord; 2008 Feb; 10(1):45-55. PubMed ID: 18199241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Supersensitivity of isolated rat vas deferens to dopamine in animals pretreated wit reserpine and haloperidol (author's transl)].
    Alloza JL; Salva JA
    Arch Farmacol Toxicol; 1980 Aug; 6(2):119-30. PubMed ID: 7469495
    [No Abstract]   [Full Text] [Related]  

  • 27. Physiology of the normal and dopamine-depleted basal ganglia: insights into levodopa pharmacotherapy.
    Grace AA
    Mov Disord; 2008; 23 Suppl 3():S560-9. PubMed ID: 18781673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia.
    Keck PE; McElroy SL; Strakowski SM; Soutullo CA
    J Clin Psychiatry; 2000; 61 Suppl 4():33-8. PubMed ID: 10739329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metoclopramide-induced supersensitivity psychosis.
    Lu ML; Pan JJ; Teng HW; Su KP; Shen WW
    Ann Pharmacother; 2002 Sep; 36(9):1387-90. PubMed ID: 12196057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesolimbic alpha-, but not beta-adrenoceptors control the accumbal release of dopamine that is derived from reserpine-sensitive storage vesicles.
    Verheij MM; Cools AR
    Neuroscience; 2009 Sep; 162(4):1163-73. PubMed ID: 19464350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bipolar affective symptoms associated with use of captopril and abrupt withdrawal of pargyline and propranolol.
    McMahon T
    Am J Psychiatry; 1985 Jun; 142(6):759-60. PubMed ID: 3890566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapidly induced dopaminergic supersensitivity: D1/D2 receptor participation and its prevention by an MAO-inhibitor.
    Kleinman A; Tieppo CA; Florez GM; Felicio LF; Nasello AG
    Pharmacol Biochem Behav; 2006 Nov; 85(3):592-600. PubMed ID: 17157367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mania secondary to left and right hemisphere damage.
    Jampala VC; Abrams R
    Am J Psychiatry; 1983 Sep; 140(9):1197-9. PubMed ID: 6614229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistent tardive rebound panic disorder, rebound anxiety and insomnia following paroxetine withdrawal: a review of rebound-withdrawal phenomena.
    Bhanji NH; Chouinard G; Kolivakis T; Margolese HC
    Can J Clin Pharmacol; 2006; 13(1):e69-74. PubMed ID: 16456219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Manic psychosis as the only clinical manifestation of hyperparathyroidism].
    Hoogduin CA; Mulder AH
    Ned Tijdschr Geneeskd; 1982 Oct; 126(44):2011-4. PubMed ID: 7177210
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychosis pathways converge via D2high dopamine receptors.
    Seeman P; Schwarz J; Chen JF; Szechtman H; Perreault M; McKnight GS; Roder JC; Quirion R; Boksa P; Srivastava LK; Yanai K; Weinshenker D; Sumiyoshi T
    Synapse; 2006 Sep; 60(4):319-46. PubMed ID: 16786561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why is it so difficult to stop psychiatric drug treatment? It may be nothing to do with the original problem.
    Moncrieff J
    Med Hypotheses; 2006; 67(3):517-23. PubMed ID: 16632226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increases in guanine nucleotide binding to striatal G proteins is associated with dopamine receptor supersensitivity.
    Butkerait P; Wang HY; Friedman E
    J Pharmacol Exp Ther; 1994 Oct; 271(1):422-8. PubMed ID: 7965743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-partum mania, dopamine, and estrogens.
    Cookson JC
    Lancet; 1982 Sep; 2(8299):672. PubMed ID: 6125807
    [No Abstract]   [Full Text] [Related]  

  • 40. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?
    Pierce RC; Kumaresan V
    Neurosci Biobehav Rev; 2006; 30(2):215-38. PubMed ID: 16099045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.